3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
9
Withdrawn
1
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
9
Leukemia, Myeloid, Acute
8
Myelodysplastic Syndromes
7
Neuroblastoma
4
Hematologic Neoplasms
4
Myeloproliferative Disorders
3
Leukemia, Myelomonocytic, Chronic
3
Graft vs Host Disease
3
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia, Biphenotypic, Acute
2
Hodgkin Disease
2
Ganglioneuroblastoma
2
Burkitt Lymphoma
2
Blastic Plasmacytoid Dendritic Cell Neoplasm
2
Teratoma
1
Rhabdoid Tumor
1
Recurrence
1
Pyloric Stenosis, Hypertrophic
1
Pinealoma
1
Neuroectodermal Tumors, Primitive
1
Medulloblastoma
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Large B-Cell, Diffuse
1
Leukemia, Myeloid
1
Leukemia, Monocytic, Acute
1
Leukemia, Mast-Cell
1
Leukemia, Lymphoid
1
Leukemia
1
Interventions
Rituximab
41
Cyclophosphamide
37
Magnetic Resonance Spectroscopy
22
Specimen Handling
20
Prednisone
19
Doxorubicin
19
polatuzumab vedotin
18
Lenalidomide
17
Biopsy
15
fludarabine
13
Oxaliplatin
13
Gemcitabine
13
Vincristine
12
zanubrutinib
11
Immunotherapy, Adoptive
11
Etoposide
10
glofitamab
8
obinutuzumab
7
axicabtagene ciloleucel
7
Prednisolone
7
ibrutinib
6
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
6
Leukapheresis
6
Injections
6
Ifosfamide
6
CT-P10
6
Bendamustine Hydrochloride
6
orelabrutinib
5
loncastuximab tesirine
5
fludarabine phosphate
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Lymphoma, Large B-Cell, Diffuse
×
Thiotepa
×
Clear all
NCT06687772
2026-03-31
CNS-PHLAT
Washington University School of Medicine
Phase 2
Recruiting
36 enrolled